Skip to main content

Find Clinical Trials

Home
Conditions
Seasonal Allergic Rhinitis

Clinical trial condition

Seasonal Allergic Rhinitis

Explore clinical trials studying Seasonal Allergic Rhinitis. Study availability and eligibility vary by location and protocol.

182 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Seasonal Allergic Rhinitis trial results

Completed

To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray

NCT04817800

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: ACDIMA Biocenter Amman, Jordan

View Trial Details

Completed

Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.

NCT05590598

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Sandoz Investigative Site Chelyabinsk, Russia

Sandoz Investigative Site Khasavyurt, Russia

Sandoz Investigative Site Krasnodar, Russia

Sandoz Investigative Site Nal'chik, Russia

View all 15 locations

View Trial Details

Completed

Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis

NCT05311475

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Sandoz Investigative Site Burgas, Bulgaria

Sandoz Investigative Site Gabrovo, Bulgaria

Sandoz Investigative Site Plovdiv, Bulgaria

Sandoz Investigative Site Sliven, Bulgaria

View all 28 locations

View Trial Details

Completed

Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics

NCT04670627

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +9 more
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis

NCT05098522

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Hammersmith Medicines Research London, United Kingdom

King's College London London, United Kingdom

View Trial Details

Completed

Dymista Allergen Chamber - Onset of Action Study

NCT04652245

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Cliantha Research Mississauga, Ontario, Canada

View Trial Details

Completed

MP-AzeFlu Allergen Chamber - Onset of Action Study

NCT03004131

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Inflamax Research Mississauga, Ontario, Canada

View Trial Details

Completed

Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)

NCT00794846

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)

NCT00794768

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)

NCT00794495

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details